GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia
Clinical trial NCT01345253 · COMPLETED
Trial details
- NCT number
- NCT01345253
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-23
- Primary completion
- 2015-09-15
- Enrollment
- 709
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.